McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
579.74
+0.52 (0.09%)
Dec 20, 2024, 4:00 PM EST - Market closed
McKesson Revenue
McKesson had revenue of $93.65B in the quarter ending September 30, 2024, with 21.29% growth. This brings the company's revenue in the last twelve months to $330.19B, up 13.43% year-over-year. In the fiscal year ending March 31, 2024, McKesson had annual revenue of $308.95B with 11.65% growth.
Revenue (ttm)
$330.19B
Revenue Growth
+13.43%
P/S Ratio
0.23
Revenue / Employee
$6,474,255
Employees
51,000
Market Cap
73.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
| Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
| Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
| Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
| Mar 31, 2020 | 231.05B | 16.73B | 7.81% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CVS Health | 367.25B |
| Cencora | 293.96B |
| The Cigna Group | 229.75B |
| Elevance Health | 174.02B |
| HCA Healthcare | 69.62B |
| GSK | 41.97B |
| Becton, Dickinson and Company | 20.18B |
| Haleon | 15.07B |
MCK News
- 14 days ago - 12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style - Seeking Alpha
- 17 days ago - McKesson Corporation (MCK) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) - Seeking Alpha
- 19 days ago - Jim Cramer lists 10 stocks likely to perform well in December - CNBC
- 6 weeks ago - McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network - Seeking Alpha
- 6 weeks ago - These Analysts Boost Their Forecasts On McKesson Following Upbeat Earnings - Benzinga
- 6 weeks ago - McKesson Corporation (MCK) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - McKesson raises annual profit forecast on strength in its U.S. pharma segment - Reuters
- 6 weeks ago - McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance - Business Wire